Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Nutritional habits modifications have shown an important impact in preventing and ameliorating metabolic alterations, such as nonalcoholic fatty liver disease (NAFLD). Among several dietary approaches that exert positive effects in NAFLD patients, the Mediterranean dietary pattern has shown notable benefits. This review explores the molecular mechanisms through which the Mediterranean diet would improve risk factors associated with metabolic syndrome and NAFLD. The main features of the Mediterranean diet acting on metabolism are represented by its whole-grain and low glycemic index cereal-based items, its fatty acid profile, and its content in phytochemical compounds. Carbohydrate-rich foods high in dietary fiber inducing low glycemic response are able to interact with glucose and insulin metabolism. Unsaturated fatty acids are associated with better hepatic lipid metabolism. Finally, phytochemical compounds, such as dietary polyphenols, are thought to ameliorate inflammation, which is considered one of the mechanisms through which NALFD may evolve into nonalcoholic steatohepatitis (NASH).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“Whole-grain cereals may influence gut microbiota composition in humans, which has been recently hypothesized to play a role in with fatty liver disease (Tremaroli & Backhed 2012).”
BackgroundSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“An estimation of the contribution suggests that approximately 60% of liver triglyceride content was derived from free fatty acid influx from adipose tissue, 26% from de novo lipogenesis, and 15% from the diet (Donnelly et al. 2005).”
BackgroundIncreased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · cited 8×
“Studies performed in adults showed a beneficial role of vitamin E supplementation in patients with NAFLD or NASH, although its effect on liver histology and enzymes are still contrasting due to negative outcomes associated with intake of high doses (Di Sario et al. 2007).”
BackgroundInfluentialA lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 2×
“2011), but conversely they were reduced in NASH patients compared with healthy individuals (Puri et al. 2007; Allard et al. 2008).”
BackgroundResultLiu, S., Willett, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., & Manson, J. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1455 · Cited by 1,166 · cited 2×
“Moreover, reductions in hepatic triacylglycerols (Jenkins et al. 1987) and C-reactive protein synthesis (Liu et al. 2000), observed with low-GI diets, may also be factors in preventing the progression of NAFLD and more serious clinical consequences.”
BackgroundRyan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Augustin, L. S. A., Kendall, C. W. C., Jenkins, D. J. A., Willett, W. C., Astrup, A., Barclay, A. W., Björck, I., Brand-Miller, J. C., Brighenti, F., Buyken, A. E., et al. (2015) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.005 · Cited by 707
Afshin, A., Micha, R., Khatibzadeh, S., & Mozaffarian, D. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076901 · Cited by 509 · cited 1×
“Findings from meta-analyses of observational studies are consistent in reporting a decreased risk of metabolic disorders related with NAFLD by increased intakes of the aforementioned foods (Wallin et al. 2012; Zhang et al. 2013; Afshin et al. 2014; Li et al. 2014; Grosso et al. 2015c).”
BackgroundMarx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice
Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., & Leclercq, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50307 · Cited by 476 · cited 1×
“PPARalpha is a transcription factor strongly active by n-3 PUFA able to reduce plasma lipids and stimulate fatty acid oxidation (Ip et al. 2003; Pawar & Jump 2003; Marx et al. 2004).”
BackgroundGrosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., Galvano, F., & Kales, S. N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1107021 · Cited by 456
N-3 polyunsaturated fatty acid regulation of hepatic gene transcription
Jump, D. B. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ffaf6a · Cited by 443
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322 · cited 1×
“The mechanisms involved in the occurrence of NAFLD and progression to NASH and cirrhosis are still unclear, probably interesting both the metabolic profile of an individual and the genetic predisposition (Bellentani & Marino 2009).”
BackgroundVolynets, V., Küper, M. A., Strahl, S., Maier, I. B., Spruss, A., Wagnerberger, S., Königsrainer, A., Bischoff, S. C., & Bergheim, I. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2112-9 · Cited by 268 · cited 1×
“The patients with NAFLD/NASH are more likely to have increased intestinal permeability compared to healthy controls and LPS-induced inflammation could be a potential determining factor in NASH (Miele et al. 2009; Volynets et al. 2012).”
BackgroundAllard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247 · cited 2×
“2011), but conversely they were reduced in NASH patients compared with healthy individuals (Puri et al. 2007; Allard et al. 2008).”
BackgroundResultHollænder, P. L., Ross, A. B., & Kristensen, M. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109165 · Cited by 233 · cited 2×
“Several meta-analyses of observational studies have found that increasing wholegrain cereal intake may reduce the risk of developing T2D, decreased likelihood of being obese, lower LDL and total cholesterol, and lower risk of deteriorating glucose tolerance (Aune et al. 2013; Pol et al. 2013; Hollaender et al. 2015).”
BackgroundBozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., Mazzarella, R., Longobardo, M., Mancini, M., Vigorito, C., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0033 · Cited by 227 · cited 2×
“Several meta-analyses of observational studies have found that increasing wholegrain cereal intake may reduce the risk of developing T2D, decreased likelihood of being obese, lower LDL and total cholesterol, and lower risk of deteriorating glucose tolerance (Aune et al. 2013; Pol et al. 2013; Hollaender et al. 2015).”
BackgroundMarventano, S., Kolacz, P., Castellano, S., Galvano, F., Buscemi, S., Mistretta, A., & Grosso, G. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1077790 · Cited by 220 · cited 1×
“In general, evidence to consider the entire n-6 PUFA family as pro-inflammatory is lacking, but effects of individual n-6 PUFA and their ratio with n3 PUFA is the focus of focus of future research (Marventano et al. 2015).”
BackgroundColonic fermentation of indigestible carbohydrates contributes to the second-meal effect
Brighenti, F., Benini, L., Del Rio, D., Casiraghi, C., Pellegrini, N., Scazzina, F., Jenkins, D. J., & Vantini, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.817 · Cited by 213
Self-citationNonalcoholic fatty liver disease – current status and future directions
Demir, M., Lang, S., & Steffen, H. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12291 · Cited by 105 · cited 2×
“Nonalcoholic fatty liver disease (NAFLD) represents the most common cause of liver disease worldwide (Demir et al. 2015).”
Background
Cited by
Non-alcoholic fatty liver disease: An expanded review
Benedict, M., & Zhang, X. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i16.715 · Cited by 751
Cobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Federico, A., Dallio, M., & Loguercio, C. (2017) · Molecules · doi:10.3390/molecules22020191 · Cited by 492
Self-citationMediterranean diet and nonalcoholic fatty liver disease
Anania, C., Perla, F. M., Olivero, F., Pacifico, L., & Chiesa, C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2083 · Cited by 353
Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism
Jegatheesan, P., & De Bandt, J. (2017) · Nutrients · doi:10.3390/nu9030230 · Cited by 280
Metadata
- Authors
- Godos, J., Federico, A., Dallio, M., & Scazzina, F.
- Venue
- International Journal of Food Sciences and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2016-08-02
- Volume
- 68
- Issue
- 1
- Pages
- 18-27
- ISSN
- 0963-7486 (ISSN-L)
- 1465-3478
- OpenAlex
- W2480953344
- Cited by
- 92
- References
- 21
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.